Daiichi Sankyo is a global pharmaceutical company based in Japan, known for its research and development of innovative medicines. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, it focuses on areas such as oncology, cardiovascular diseases, and vaccines. The company aims to improve patient health through advanced therapies and has a strong presence in both domestic and international markets. The company is also involved in various collaborations and partnerships to enhance its drug development capabilities. With a commitment to sustainability and corporate responsibility, Daiichi Sankyo strives to contribute positively to society while advancing healthcare solutions worldwide.